Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 992.1 | 1,015.6 | 767.1 | 687.3 |
| Revenue growth | -2.3% | 32.4% | 11.6% | |
| Cost of goods sold | 799.4 | 775.4 | 602.1 | 545.5 |
| Gross profit | 192.7 | 240.3 | 165.1 | 141.8 |
| Gross margin | 19.4% | 23.7% | 21.5% | 20.6% |
| Sales and marketing | 108.8 | 95.8 | 77.6 | 78.9 |
| Research and development | 40.3 | 39.2 | 29.0 | 26.4 |
| General and administrative | 57.1 | 70.7 | 48.4 | 51.0 |
| EBITA | -7.3 | 38.1 | 14.5 | -10.6 |
| EBITA margin | -0.7% | 3.7% | 1.9% | -1.5% |
| Amortization of intangibles | 6.3 | 3.5 | 4.3 | 4.0 |
| EBIT | -13.5 | 34.6 | 10.2 | -14.6 |
| EBIT margin | -1.4% | 3.4% | 1.3% | -2.1% |
| Pre-tax income | -18.6 | -14.5 | 7.7 | -15.0 |
| Income taxes | 6.0 | -25.5 | 3.3 | 5.5 |
| Tax rate | | 175.6% | 43.0% | |
| Net income | -24.6 | 11.0 | 4.4 | -20.5 |
| Net margin | -2.5% | 1.1% | 0.6% | -3.0% |
| |
| Diluted EPS | ($0.44) | $0.20 | $0.22 | ($1.34) |
| Shares outstanding (diluted) | 55.6 | 53.9 | 20.2 | 15.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|